Clinical Trial Update: Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis [Phase 1]

View source ↗

Summary

This report summarizes the completion of a Phase 1 clinical trial evaluating Bilhvax, a vaccine candidate for schistosomiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis
• Urinary Schistosomiasis

Drugs mentioned

• Bilhvax

Snippet

Sponsor: University Hospital, Lille | Conditions: Schistosomiasis, Bilharziasis | Phase 1 | Status: COMPLETED